These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2932482)

  • 1. The dexamethasone suppression test in depressive, non-depressive and schizoaffective psychosis.
    Coccaro EF; Prudic J; Rothpearl A; Nurnberg HG
    J Affect Disord; 1985 Sep; 9(2):107-13. PubMed ID: 2932482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dexamethasone suppression test in patients with postpsychotic depressions.
    Siris SG; Rifkin A; Reardon GT; Doddi SR; Foster P; Strahan A; Morgan V
    Biol Psychiatry; 1984 Sep; 19(9):1351-6. PubMed ID: 6498257
    [No Abstract]   [Full Text] [Related]  

  • 3. HPA axis hyperactivity and recovery from functional psychoses.
    Coryell WH; Zimmerman M
    Am J Psychiatry; 1989 Apr; 146(4):473-7. PubMed ID: 2929747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dexamethasone suppression test in depressed and non-depressed geriatric medical inpatients.
    Magni G; Schifano F; De Leo D; De Dominicis MG; Garbin A; Zangaglia O
    Acta Psychiatr Scand; 1986 May; 73(5):511-4. PubMed ID: 3751656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma postdexamethasone cortisol levels in schizoaffective disorder.
    Meador-Woodruff JH; Greden JF; Grunhaus L; Haskett RF
    Psychiatry Res; 1988 Oct; 26(1):35-42. PubMed ID: 3237905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased dexamethasone suppression in endogenously depressed patients with normal basal plasma levels of cortisol.
    Halbreich U; Naor S; Asnis G; Gasparini F; Goldstein S; Vital-Herne J; Kang BJ
    Biol Psychiatry; 1986 Dec; 21(14):1434-7. PubMed ID: 3790627
    [No Abstract]   [Full Text] [Related]  

  • 7. Further investigation of the dexamethasone suppression test in affective illnesses: relationship to clinical diagnosis and therapeutic response.
    Mendlewicz J; Hubain PP; Koumakis C
    Neuropsychobiology; 1984; 12(1):23-6. PubMed ID: 6514175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dexamethasone suppression test (DST): clinical use in psychiatry].
    Morrissette L; Boucher H
    Union Med Can; 1986 Jan; 115(1):58-63. PubMed ID: 3952894
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypothalamo-pituitary-adrenal activity in endogenously depressed post-traumatic stress disorder patients.
    Halbreich U; Olympia J; Carson S; Glogowski J; Yeh CM; Axelrod S; Desu MM
    Psychoneuroendocrinology; 1989; 14(5):365-70. PubMed ID: 2813658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dexamethasone suppression and metyrapone tests in depression.
    Morphy MA; Fava GA; Perini GI; Molnar G; Zielezny M; Lisansky J
    Psychiatry Res; 1985 Jun; 15(2):153-8. PubMed ID: 3862146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone suppression test and sleep deprivation in endogenous depression.
    Kuhs H
    J Affect Disord; 1985 Sep; 9(2):121-6. PubMed ID: 2932484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dexamethasone suppression test in depressed retarded adults: preliminary findings.
    Beckwith BE; Parker L; Pawlarczyk D; Couk DI; Schumacher KS; Yearwood K
    Biol Psychiatry; 1985 Aug; 20(8):825-31. PubMed ID: 4027299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major depressive episode and low dose dexamethasone suppression test.
    Sarai M; Taniguchi N; Kagomoto T; Kameda H; Uema T; Hishikawa Y
    Folia Psychiatr Neurol Jpn; 1982; 36(2):109-14. PubMed ID: 7129257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic-pituitary-adrenal axis function and platelet serotonin concentrations in depressed patients.
    Pivac N; Jakovljević M; Mück-Seler D; Brzović Z
    Psychiatry Res; 1997 Dec; 73(3):123-32. PubMed ID: 9481804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dexamethasone suppression test in prepubertal depressed children.
    Weller EB; Weller RA; Fristad MA; Preskorn SH; Teare M
    J Clin Psychiatry; 1985 Dec; 46(12):511-3. PubMed ID: 4066616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal differences between psychotic and non-psychotic melancholic depression.
    Contreras F; Menchon JM; Urretavizcaya M; Navarro MA; Vallejo J; Parker G
    J Affect Disord; 2007 Jun; 100(1-3):65-73. PubMed ID: 17098292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine interrelationships in major depressive disorder.
    Targum SD; Sullivan AC; Byrnes SM
    Am J Psychiatry; 1982 Mar; 139(3):282-6. PubMed ID: 6800269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of abnormal dexamethasone suppression test in alcoholics abstinent for four weeks.
    Del Porto JA; Monteiro MG; Laranjeira RR; Jorge MR; Masur J
    Biol Psychiatry; 1985 Nov; 20(11):1156-60. PubMed ID: 4052517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypothalamic-pituitary-adrenal system in panic disorder.
    Goldstein S; Halbreich U; Asnis G; Endicott J; Alvir J
    Am J Psychiatry; 1987 Oct; 144(10):1320-3. PubMed ID: 3661766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of weight loss on the dexamethasone suppression test.
    Yerevanian BI; Baciewicz GJ; Iker HP; Privitera MR
    Psychiatry Res; 1984 Jun; 12(2):155-60. PubMed ID: 6591220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.